A Tripeptide Diapin Effectively Lowers Blood Glucose Levels in Male Type 2 Diabetes Mice by Increasing Blood Levels of Insulin and GLP-1

The prevalence of type 2 diabetes (T2D) is rapidly increasing worldwide. Effective therapies, such as insulin and Glucagon-like peptide-1 (GLP-1), require injections, which are costly and result in less patient compliance. Here, we report the identification of a tripeptide with significant potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jifeng, Xue, Changyong, Zhu, Tianqing, Vivekanandan, Anuradha, Pennathur, Subramaniam, Ma, Zhongmin Alex, Chen, Y. Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873933/
https://www.ncbi.nlm.nih.gov/pubmed/24386218
http://dx.doi.org/10.1371/journal.pone.0083509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873933/
https://www.ncbi.nlm.nih.gov/pubmed/24386218
http://dx.doi.org/10.1371/journal.pone.0083509

Ejemplares similares